genae Opens Offices in Warsaw

ANTWERP, Belgium and WARSAW, Poland --

genae, a global Contract Research Organization (CRO) and services provider for the medical industries, today announced the incorporation of genae Poland in Warsaw.

"Poland is the most populated country in Central and Eastern Europe (CEE) and features qualified and experienced researchers and supportive medical staff. This gives it strong potential for increased patient recruitment while maintaining high quality of data at a competitive cost." said Bart Segers, CEO at genae. "The offices in Warsaw further enhance our commitment to offering a global CRO reach by implementing local anchoring".

Warsaw is the largest financial and economic hub of CEE. The city is Poland's top academic center and the most important destination for R&D in the country. Its young, motivated and highly skilled workforce has international experience as well as strong foreign-language skills. Two airports, Chopin and Modlin, connect Warsaw to the rest of Europe and the world.

About genae

genae is involved in the development and commercialization of medical devices, biologics and therapies that change medical practice.

genae is a full service CRO and an innovative services provider for the medical industries and aims at improving health and quality of life by innovating and accelerating high quality research. The group is ISO 9001 certified for clinical trial management, data management, statistical analysis, safety, regulatory, core laboratory and medical writing services for the medical industries.

genae associates nv is a privately held company with principal offices in Antwerp, Belgium and is part of the genae group, the medical device CRO.

To learn more about genae, please visit

Contact: Bart Segers, CEO, [email protected], +32-3-290-03-06 (office)

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.